A Payment Incentive to Improve Confirmatory Testing in Men With Prostate Cancer

Was a payment incentive, as part of a multifaceted intervention, associated with an increase in confirmatory testing completion (magnetic resonance imaging, repeat prostate biopsy, or genomics test) among men with low-risk prostate cancer?In a cohort study of 6609 patients, confirmatory testing completion increased over the study period, from 2017 to 2022. Patients who received the incentive had a 7.5% increase in predicted probability of confirmatory testing relative to the preincentive period, but this finding was not statistically significant.This study suggests that the payment incentive was not associated with a robust increase in confirmatory testing, highlighting the potential as well as the challenges of alternative payment model development.

Corresponding Author: Arnav Srivastava, MD, MPH, MS, Dow Division of Health Services Research, Department of Urology, University of Michigan, 2800 Plymouth Rd, Building 16, Ann Arbor, MI 48109 (srivasar@med.umich.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.